• Botanical Solution Inc. (BSI)

    Supplying scalable and sustainable key botanical products

  • Botanical Solution Inc. (BSI)

    Supplying scalable and sustainable key botanical products

12

Environmental awareness

The traditional botanical market is expected to exceed $17.8 billion in value by 2025 across diverse market segments that include pharma, food and beverages, and cosmetics among other relevant industries.

However, traditional botanical products are seriously affected by critical issues related to supply and quality of raw materials, often obtained under exploitation of natural resources with a sizeable environmental footprint.

BSI has developed a proprietary technology that allows a scalable and sustainable supply of key botanical products, with none of the issues related to current production of traditional botanical raw materials and active ingredients.

Proprietary R&D Platform

A unique and patented R&D platform, based on plant tissue culture, allows BSI to discover and develop botanical products that are sustainable, highly consistent and cost effective. This R&D platform eliminates the major barriers, such as supply and quality issues, that have prevented traditional botanicals from becoming truly commercially successful.

BSI has developed “ABM-01” based on a plant which is native to Chile, named Quillaja saponaria Molina. This product is the active ingredient used by BSI to produce the biopesticide Botristop®, and it will enable the production of the vaccine adjuvant QS-21 soon.

Competitive Advantages

Better
Quality

Better
Manufacturing

Better Competitive Position

  • Attributes
  • Material
  • Cost
  • Scalability
  • Differentiation
  • Intellectual Property
  • Traditional Botanicals
  • Raw Material
  • Growing Costs and Lower Margins
  • Limited
  • Commodity
  • None
  • Advanced Botanicals
  • Curated Material
  • Growing Margins and Lower Costs
  • High
  • Proprietary
  • Patents and Trade Secrets

Pharma

QS-21 is a “Gold Standard vaccine adjuvant” that will face an imminent shortage of supply soon according to different sources. Today there is only one QS-21 adjuvanted vaccine on the market, but dozens more are underway in different clinical trial stages, including several COVID-19 vaccine candidates, due to its remarkable stimulant action of immune response, which has been extensively studied for over two decades and validated in multiple large scale clinical trials worldwide.

QS-21 is originally extracted from a tree’s bark called Quillaja saponaria that grows wildly in Chile, and its exploitation is strictly controlled by local authorities.

This new product, now under development by BSI, will solve a supply problem by providing as much of this valuable, highly demanded compound as needed.

Agriculture

Agriculture

Botristop® is a broad spectrum biofungicide with a superior performance to prevent and control Botrytis cinerea, one of the most harmful fungal diseases in high value crops worldwide, responsible for hundreds of millions of dollars in losses every year.

Botristop®’s unique modes of action allow worldwide exports of top quality fresh produce, while meeting the world’s strictest MRL guidelines (Maximum Residue Limits).

Botristop® has been successfully launched and commercialized in Chile through a partnership between BSI and Syngenta since 2019, and will soon be registered in a number of key countries. This product will not be offered for sale or sold in the US under the name BOTRISTOP.

 

Excellent Botrytis control when used alone, as good as commercial standards and IPM programs.

Get in touch

BSI is a venture-backed corporation based in Davis, California with subsidiary businesses in Latin America.

@ Copyright - Botanical Solution Inc   |   All Rights Reserved